![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Physiological functions of D-amino acid oxidases: from yeast to humans
D-Amino acid oxidase (DAAO) is a FAD-containing flavoenzyme that catalyzes the oxidative deamination of D-isomers of neutral and polar amino acids. This enzymatic activity has been identified in most eukaryoti...
-
Article
Distinct genomic events in the myeloid and lymphoid lineages in simultaneous presentation of chronic myeloid leukemia and B-chronic lymphocytic leukemia
-
Article
Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling
Objective: This study investigated the pharmacokinetics of tretinoin during alternating cycles of 1 week of tretinoin treatment and 1 week drug-free in patients with Ph1+ chronic myelogenous leuk...
-
Article
All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase
Since in vitro observations indicated that all-trans retinoic acid (ATRA), especially in combination with IFNα, can exert significant suppressive effects on Ph+ cells, we investigated the effects and the pharmaco...
-
Article
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone
The efficacy of alfa-interferon (alfa-IFN) in essential thrombocythemia (ET) patients has been reported by several authors. The aim of this study is to assess the magnitude of the effect of alfa-IFN on the neo...
-
Article
Long-term follow-up results of alpha-interferon-based regimens in patients with late chronic phase chronic myelogenous leukemia
The aim of this analysis was to evaluate the efficacy of alpha-interferon (α-IFN) regimens in late chronic phase (diagnosis >12 months) chronic myelogenous leukemia (CP-CML). Long-term follow-up results were e...
-
Article
A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera
Interferon alpha (α-IFN) is increasingly used for the treatment of patients affected by polycythemia vera (PV). As prior studies are difficult to interpret in view of the lack of appropriate controls, we under...
-
Article
Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term α-IFN treatment
In essential thrombocythemia patients α-IFN rapidly reduces platelet count, and it is also able to maintain a low count during long-term treatment. In order to verify if long-term IFN treatment can produce sus...
-
Article
Interferon alpha-2b in the long-term treatment of essential thrombocythemia
We treated 35 patients affected with essential thrombocythemia (ET) with interferon (IFN) alpha-2b. Our treatment scheme consisted of (a) a 6-month induction phase and (b) a continuous maintenance phase. Durin...
-
Article
Sinus histiocytosis with massive lymphadenopathy: Immunological, cytogenetic and molecular studies
We describe a case of “sinus histiocytosis with massive lymphadenopathy” (SHML) studied by immunohistochemical, cytogenetic and molecular analysis. The immunophenoty** showed that the lymph node histiocytes ...
-
Article
In vivo andin vitro HeNe laser effects on phagocyte functions
The goal of this work was to evaluate the effect of helium-neon (HeNe) laser irradiation on immunocompetent cells. We used the in vivo skin window method and in vitro granulocyte function tests. The study of c...